Was betrifft es? Warum ist das wichtig?

Swissmedic provides internet-based eGov services (Electronic Government). These are electronic services that include access-protected legal transactions for the sharing of information and data.

 

The Swissmedic eGov portal is used by researchers to submit their application for study approval, which include Medicinal Products (MP) and Advanced Therapy Medicinal Products (ATMP) studies.

 

Submissions of Medical Device (MD), In Vitro Diagnostic (IVD), and combined studies (e.g. MD & MP) are submitted using the eGov Service eMessage portal.

 

All Swissmedic eGov services are accessed via the eGov Portal.

Was muss ich befolgen?

Depending on the selected eGov service, as a SP-INV either:

  • Register yourself as a user, and / or
  • Create a user administrator account for your organization. A user administrator can assign access rights to other users within the same organization.

Wo kann ich Hilfe anfordern?

Your local Research Support Centre can assist you with experienced staff regarding this topic

  • Basel, Departement Klinische Forschung (DKF), dkf.unibas.ch

  • Lugano, Clinical Trials Unit (CTU-EOC), ctueoc.ch

  • Bern, Department of Clinical Research (DCR), dcr.unibe.ch

  • Geneva, Clinical Research Center (CRC), crc.hug.ch

  • Lausanne, Clinical Research Center (CRC), chuv.ch

  • St. Gallen, Clinical Trials Unit (CTU), h-och.ch

  • Zürich, Clinical Trials Center (CTC), usz.ch

External Links

Swissmedic – see in particular

Abkürzungen
  • ATMP – Advanced Therapy Medicinal Products
  • CTU – Clinical Trials Unit
  • eGov – Electronic Government
  • IVD – In Vitro Diagnostic
  • MD – Medical Device
  • MP – Medicinal Product
  • SP-INV – Sponsor Investigator
Basic ↦ Ethics and Laws ↦ Submission Portal ↦ Swissmedic eGov Portal
Study
Basic

Provides some background knowledge and basic definitions

Basic Monitoring
Concept

Starts with a study idea

Ends after having assessed and evaluated study feasibility

Concept Statistic Methodology
Concept Drug or Device
Development

Starts with confidence that the study is feasible

Ends after having received ethics and regulatory approval

Development Drug or Device
Set-Up

Starts with ethics and regulatory approval

Ends after successful study initiation

Set-Up Ethics and Laws
Set-Up Statistic Methodology
Set-Up Quality and Risk
Set-Up Drug or Device
Conduct

Starts with participant recruitment

Ends after the last participant has completed the last study visit

Conduct Statistic Methodology
Conduct Drug or Device
Completion

Starts with last study visit completed

Ends after study publication and archiving

Completion Drug or Device
Current Path (click to copy): Basic ↦ Ethics and Laws ↦ Submission Portal ↦ Swissmedic eGov Portal

Please note: the Easy-GCS tool is currently under construction.